Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Immucell Cp (ICCC)

Immucell Cp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Immucell Cp 56 EVERGREEN DR PORTLAND ME 04103 USA

www.immucell.com P: 207-878-2770

Description:

ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea.

Key Statistics

Overview:

Market Capitalization, $K 39,064
Enterprise Value, $K 50,054
Shares Outstanding, K 7,751
Annual Sales, $ 17,470 K
Annual Net Income, $ -5,770 K
Last Quarter Sales, $ 5,100 K
Last Quarter Net Income, $ -1,140 K
EBIT, $ -5,740 K
EBITDA, $ -3,000 K
60-Month Beta 0.59
% of Insider Shareholders 6.30%
% of Institutional Shareholders 13.47%
Float, K 7,263
% Float 93.70%
Short Volume Ratio 0.30

Growth:

1-Year Return 3.45%
3-Year Return -53.97%
5-Year Return -15.01%
5-Year Revenue Growth 58.96%
5-Year Earnings Growth -78.57%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.15 on 02/27/24
Latest Earnings Date 05/09/24
Earnings Per Share ttm -0.75
EPS Growth vs. Prev Qtr -25.00%
EPS Growth vs. Prev Year 31.82%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-2 on 12/23/04

ICCC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -21.79%
Return-on-Assets % -13.16%
Profit Margin % -33.03%
Debt/Equity 0.48
Price/Sales 2.23
Price/Cash Flow N/A
Price/Book 1.56
Book Value/Share 3.22
Interest Coverage -0.11
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar